Continuous subcutaneous infusion of pramipexole protects against lipopolysaccharide-induced dopaminergic cell death without affecting the inflammatory response. (Q46525400)
Jump to navigation
Jump to search
scientific article published on 14 May 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Continuous subcutaneous infusion of pramipexole protects against lipopolysaccharide-induced dopaminergic cell death without affecting the inflammatory response. |
scientific article published on 14 May 2008 |
Statements
Continuous subcutaneous infusion of pramipexole protects against lipopolysaccharide-induced dopaminergic cell death without affecting the inflammatory response (English)
Mona Sadeghian
Banu C Tel
Sarah Rose